141 related articles for article (PubMed ID: 30011084)
1. The proto-oncogene function of Mdm2 in bone.
Olivos DJ; Perrien DS; Hooker A; Cheng YH; Fuchs RK; Hong JM; Bruzzaniti A; Chun K; Eischen CM; Kacena MA; Mayo LD
J Cell Biochem; 2018 Nov; 119(11):8830-8840. PubMed ID: 30011084
[TBL] [Abstract][Full Text] [Related]
2. Osteoblast differentiation and skeletal development are regulated by Mdm2-p53 signaling.
Lengner CJ; Steinman HA; Gagnon J; Smith TW; Henderson JE; Kream BE; Stein GS; Lian JB; Jones SN
J Cell Biol; 2006 Mar; 172(6):909-21. PubMed ID: 16533949
[TBL] [Abstract][Full Text] [Related]
3. Deletion of OPN in BSP knockout mice does not correct bone hypomineralization but results in high bone turnover.
Bouleftour W; Juignet L; Verdière L; Machuca-Gayet I; Thomas M; Laroche N; Vanden-Bossche A; Farlay D; Thomas C; Gineyts E; Concordet JP; Renaud JB; Aubert D; Teixeira M; Peyruchaud O; Vico L; Lafage-Proust MH; Follet H; Malaval L
Bone; 2019 Mar; 120():411-422. PubMed ID: 30529011
[TBL] [Abstract][Full Text] [Related]
4. Progressive ankylosis protein (ANK) in osteoblasts and osteoclasts controls bone formation and bone remodeling.
Kim HJ; Minashima T; McCarthy EF; Winkles JA; Kirsch T
J Bone Miner Res; 2010 Aug; 25(8):1771-83. PubMed ID: 20200976
[TBL] [Abstract][Full Text] [Related]
5. Genetic analysis of Raf1, Mdm2, c-Myc, Cdc25a and Cdc25b proto-oncogenes in 2',3'-dideoxycytidine- and 1,3-butadiene-induced lymphomas in B6C3F1 mice.
Zhuang S; Söderkvist P
Mutat Res; 2000 Jul; 452(1):19-26. PubMed ID: 10894886
[TBL] [Abstract][Full Text] [Related]
6. Osteoblast-specific inactivation of p53 results in locally increased bone formation.
Liao N; Koehne T; Tuckermann J; Triviai I; Amling M; David JP; Schinke T; Luther J
PLoS One; 2021; 16(11):e0249894. PubMed ID: 34793446
[TBL] [Abstract][Full Text] [Related]
7. [Therapeutic effects of small interfering RNA targeting MDM2 on human osteosarcoma cells].
Lü JY; Gao ZL; Wang JC; Wu DK; Zhao DX; Zhang DD; Zhao YY
Zhonghua Zhong Liu Za Zhi; 2008 Jul; 30(7):502-5. PubMed ID: 19062715
[TBL] [Abstract][Full Text] [Related]
8. MDM2 antagonist Nutlin-3 suppresses the proliferation and differentiation of human pre-osteoclasts through a p53-dependent pathway.
Zauli G; Rimondi E; Corallini F; Fadda R; Capitani S; Secchiero P
J Bone Miner Res; 2007 Oct; 22(10):1621-30. PubMed ID: 17592964
[TBL] [Abstract][Full Text] [Related]
9. The E3 ubiquitin protein ligase MDM2 dictates all-trans retinoic acid-induced osteoblastic differentiation of osteosarcoma cells by modulating the degradation of RARα.
Ying M; Zhang L; Zhou Q; Shao X; Cao J; Zhang N; Li W; Zhu H; Yang B; He Q
Oncogene; 2016 Aug; 35(33):4358-67. PubMed ID: 26776160
[TBL] [Abstract][Full Text] [Related]
10. Loss of MMP-2 disrupts skeletal and craniofacial development and results in decreased bone mineralization, joint erosion and defects in osteoblast and osteoclast growth.
Mosig RA; Dowling O; DiFeo A; Ramirez MC; Parker IC; Abe E; Diouri J; Aqeel AA; Wylie JD; Oblander SA; Madri J; Bianco P; Apte SS; Zaidi M; Doty SB; Majeska RJ; Schaffler MB; Martignetti JA
Hum Mol Genet; 2007 May; 16(9):1113-23. PubMed ID: 17400654
[TBL] [Abstract][Full Text] [Related]
11. The mdm2 proto-oncogene.
Haines DS
Leuk Lymphoma; 1997 Jul; 26(3-4):227-38. PubMed ID: 9322885
[TBL] [Abstract][Full Text] [Related]
12. Detection of MDM2-proto-oncogene in paraffin embedded human bronchial epithelium.
Wiethege T; Voss B; Müller KM
J Cancer Res Clin Oncol; 1994; 120(4):252-5. PubMed ID: 8288680
[TBL] [Abstract][Full Text] [Related]
13. Bone loss in C57BL/6J-OlaHsd mice, a substrain of C57BL/6J carrying mutated alpha-synuclein and multimerin-1 genes.
Liron T; Raphael B; Hiram-Bab S; Bab IA; Gabet Y
J Cell Physiol; 2018 Jan; 233(1):371-377. PubMed ID: 28266709
[TBL] [Abstract][Full Text] [Related]
14. Reduced trabecular bone mass and strength in mice overexpressing Gα11 protein in cells of the osteoblast lineage.
Dela Cruz A; Mattocks M; Sugamori KS; Grynpas MD; Mitchell J
Bone; 2014 Feb; 59():211-22. PubMed ID: 24308950
[TBL] [Abstract][Full Text] [Related]
15. A new subtype of high-grade mandibular osteosarcoma with RASAL1/MDM2 amplification.
Guérin M; Thariat J; Ouali M; Bouvier C; Decouvelaere AV; Cassagnau E; Aubert S; Lepreux S; Coindre JM; Valmary-Degano S; Larousserie F; Meilleroux J; Projetti F; Stock N; Galant C; Marie B; Peyrottes I; de Pinieux G; Gomez-Brouchet A
Hum Pathol; 2016 Apr; 50():70-8. PubMed ID: 26997440
[TBL] [Abstract][Full Text] [Related]
16. Bcl6 promotes osteoblastogenesis through Stat1 inhibition.
Fujie A; Funayama A; Miyauchi Y; Sato Y; Kobayashi T; Kanagawa H; Katsuyama E; Hao W; Tando T; Watanabe R; Morita M; Miyamoto K; Kanaji A; Morioka H; Matsumoto M; Toyama Y; Miyamoto T
Biochem Biophys Res Commun; 2015 Feb; 457(3):451-6. PubMed ID: 25597995
[TBL] [Abstract][Full Text] [Related]
17. Transgenic overexpression of tartrate-resistant acid phosphatase is associated with induction of osteoblast gene expression and increased cortical bone mineral content and density.
Gradin P; Hollberg K; Cassady AI; Lång P; Andersson G
Cells Tissues Organs; 2012; 196(1):68-81. PubMed ID: 22248481
[TBL] [Abstract][Full Text] [Related]
18. MDM2 and CDK4 expression in periosteal osteosarcoma.
Righi A; Gambarotti M; Benini S; Gamberi G; Cocchi S; Picci P; Bertoni F
Hum Pathol; 2015 Apr; 46(4):549-53. PubMed ID: 25680902
[TBL] [Abstract][Full Text] [Related]
19. Phosphorylation of the Mdm2 oncoprotein by the c-Abl tyrosine kinase regulates p53 tumor suppression and the radiosensitivity of mice.
Carr MI; Roderick JE; Zhang H; Woda BA; Kelliher MA; Jones SN
Proc Natl Acad Sci U S A; 2016 Dec; 113(52):15024-15029. PubMed ID: 27956626
[TBL] [Abstract][Full Text] [Related]
20. Linkage of decreased bone mass with impaired osteoblastogenesis in a murine model of accelerated senescence.
Jilka RL; Weinstein RS; Takahashi K; Parfitt AM; Manolagas SC
J Clin Invest; 1996 Apr; 97(7):1732-40. PubMed ID: 8601639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
